- Home
- RJET vs CRON Comparison
RJET vs CRON Comparison
Compare RJET & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RJET | CRON |
|---|---|---|
| Founded | 1982 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 961.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RJET | CRON |
|---|---|---|
| Price | $18.67 | $2.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 20.1K | ★ 1.2M |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 93.20 | 0.09 |
| Revenue | ★ $1,597,200,000.00 | $132,357,000.00 |
| Revenue This Year | N/A | $19.67 |
| Revenue Next Year | N/A | $30.56 |
| P/E Ratio | ★ $0.19 | $26.71 |
| Revenue Growth | 3.14 | ★ 19.00 |
| 52 Week Low | $17.35 | $1.60 |
| 52 Week High | $21.57 | $3.16 |
Technical Indicators
Market Signals| Indicator | RJET | CRON |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 53.40 |
| Support Level | N/A | $2.44 |
| Resistance Level | N/A | $2.50 |
| Average True Range (ATR) | 0.00 | 0.08 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 81.96 |
Price Performance
Historical ComparisonAbout RJET Republic Airways Holdings Inc. Common Stock
Republic Airways Holdings Inc operates a fleet of 240+ Embraer 170/175 aircraft and offers scheduled passenger service with daily flights to cities across the U.S., Canada, the Caribbean and Central America.
About CRON Cronos Group Inc.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.